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ABSTRACT
Background & Aims: Mdr2 P-glycoprotein (Pgp) deficiency in mice leads to
formation of phospholipid- and cholesterol-depleted bile. Plasma HDL cholesterol
is strongly reduced in Mdr2 Pgp-deficient (Mdr2(-/-)) mice. This study addresses the
following questions 1: does plasma HDL in Mdr2(-/-) mice increase upon
phospholipid and/or cholesterol feeding, and 2: is the liver of Mdr2(-/-) mice capable
of handling excess dietary cholesterol. Methods: Male and female Mdr2(-/-) and
wildtype Mdr2(+/+) mice were fed semi-synthetic diets with or without additional
phosphatidylcholine for two weeks, with or without additional cholesterol for
another week. Plasma, hepatic and biliary lipids were measured, as well as
parameters of liver function and expression of transport proteins involved in bile
formation. Results: Feeding excess phospholipids and/or cholesterol did not affect
plasma lipoprotein levels in either Mdr2(+/+) or Mdr2(-/-) mice. Dietary cholesterol led
to a marked hyperbilirubinemia in male (+100%) and female (+500%) Mdr2(-/-)
mice, both in the presence and absence of phospholipids. Plasma bile salt levels
increased by 200% in males and by 1250% in females. These effects were not
observed in Mdr2(+/+) mice. Bile flow, biliary bile salt secretion nor biliary bilirubin
secretion were affected in Mdr2(-/-) mice by cholesterol feeding. Increased plasma
bile salt levels may be related to cholesterol-induced reduction of Na+-
taurocholate cotransporting protein (Ntcp) expression in livers of Mdr2(-/-) mice.
Conclusion: Excess dietary phospholipids and cholesterol do not normalize low
HDL levels associated with Mdr2 Pgp-deficiency. Induction of hypercholanemia
and hyperbilirubinemia by dietary cholesterol in Mdr2(-/-) mice delineates the
important role of biliary lipid secretion in normal hepatic functioning.
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INTRODUCTION
The biliary pathway is considered the major route for removal of excess cholesterol
from the body [1,2]. Cholesterol, either as such or after its conversion to bile salts,
is expelled through bile into the intestinal lumen followed by fecal elimination.
However, the majority of bile salts and a considerable fraction of biliary cholesterol,
approximately 65% [3], is reabsorbed from the intestine. Bile salts are transported
back to the liver via the portal system for resecretion into bile. The physiological
importance of this so-called enterohepatic circulation of bile salts in the regulation
of hepatic bile salt and cholesterol synthesis [1,4], LDL receptor activity [5] and
VLDL formation [6,7] is well-established. Less is known about the physiological
significance of biliary cholesterol reabsorption. In this respect, it is of importance to
note that the amount of cholesterol entering the intestine via bile, up to 1200
mg/day in humans [1], is typically two to three times larger than the amount of
dietary cholesterol. Biliary cholesterol is accompanied by a six- to eight-fold excess
of bile specific phospholipids, mainly phosphatidylcholine with 16:0-18:1, 16:-18:2
or 16:0-20:4 configuration. These phospholipids are essential for secretion of
biliary cholesterol [8,9] and for protection of the biliary tree against the cytotoxic
actions of bile salts [10-12]. In addition, it has been described that biliary
phospholipids have a stimulatory action on formation of chylomicrons by
enterocytes [13-15] and, therefore, may be essential for efficient absorption of
cholesterol. Little is known about the role of biliary cholesterol and phospholipids
per se in the maintenance of cholesterol homeostasis and in the regulation of
plasma cholesterol levels. This is mainly due to the fact that secretion of these
lipids is coupled to that of bile salts. As a consequence, it has not been possible to
study the actions of biliary lipids independent from those of bile salts in the in vivo
situation. Recently generated Mdr2 P-glycoprotein (Pgp)-deficient mice (Mdr2(-/-)
mice) [8-10] provide us with the tool to address this issue. Mdr2 Pgp acts as an
ATP-dependent “flippase”, translocating phosphatidylcholine from the inner to the
outer leaflet of the bile canalicular membrane [8,10]. Mdr2 Pgp-deficient mice are
unable to secrete phospholipids into bile and, as a consequence, do not secrete
cholesterol under physiological conditions [8,10]. Bile salt secretion, on the other
hand, is not affected in these animals [8,10].
In a previous study [16], we observed that mice homozygous for Mdr2 gene
disruption have strongly reduced plasma HDL-cholesterol levels (- 65%) when fed
normal laboratory chow. Heterozygous Mdr2(+/-) mice show a 25% reduction in
plasma HDL-cholesterol compared with wild type controls [16]. We hypothesized
that reduced HDL cholesterol levels in Mdr2(-/-) mice are due to the absence of
biliary lipids in the intestine leading to impaired chylomicron formation [15]. Our
aim for the present study was: 1. to evaluate whether or not the phenotype of Mdr2
Pgp-deficient mice with respect to plasma lipoprotein levels can be restored by
addition of phosphatidylcholine and/or cholesterol to the diet and 2. to investigate
whether the liver of these mice is able to handle excess dietary cholesterol despite
impaired hepatobiliary cholesterol secretion. For this purpose we supplied mice
with dietary egg-phosphatidylcholine (PC), the composition of which resembles
that of biliary PC, with or without additional cholesterol. PC and cholesterol were
added to the diets in amounts equivalent to respectively ten-times and thirty-times
the daily biliary load of these lipids in control mice. Data show no effects of dietary
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PC and cholesterol on plasma lipid levels in Mdr2(-/-) mice, indicating a specific
role of biliary lipid secretion in regulation of plasma HDL levels. However,
cholesterol feeding resulted in a marked hyperbilirubinemia and hypercholanemia
in Mdr2(-/-) mice, with elevated plasma alkaline phosphatase activities. To the best
of our knowledge, this is the first description of hypercholanemia and
hyperbilirubinemia induced by dietary cholesterol in an in vivo model.
MATERIALS AND METHODS
Animals: Control Mdr2(+/+) and Mdr2 knockout Mdr2(-/-) mice, 25-30 g,  were
obtained from the breeding colony at the Academic Medical Center, Amsterdam.
Animals were kept on a semi-purified diet, the composition of which is shown in
Table 1 (Hope Farms BV, Woerden, The Netherlands), for two weeks before
starting the experiment. After these two weeks, the mice were randomly divided
into two groups, one group (males and females) continuing on the same semi-
purified diet and the other group receiving the same diet supplemented with 11.3
mmol/kg PC. Animals received these diets for a period of two weeks and were
than subdivided again, with half of the animals remaining on their diet and the
other half receiving the same diet supplemented with 0.25% cholesterol (6.5
mmol/kg), resulting in n = 8 per dietary group for both sexes (see Figure 1). Food
and water were available ad libitum. The experimental procedure was approved by
the Ethical Committee for Animal Experiments of the University of Groningen.
Table 1: Composition of the semi-purified diet (reference diet) as purchased from Hope









Experimental procedures: Blood samples were collected at baseline (day 0), after
one (day 7) and two (day 14) weeks on semi-purified diets with or without PC and
Figure 1: Design of the
experiment, showing the
different dietary groups
and the time points of
blood sampling during the
experiment.
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after 3 (day 17) and 7 (day 21) days of cholesterol feeding, as indicated in Figure 1.
Small blood samples at days 0, 7, 14 and 17 were collected by tail bleeding under
light halothane anesthesia. At day 21, the gallbladder of mice was canulated under
Hypnorm (fentanyl/fluanisone, 1 mL/kg) and Diazepam (10 mg/kg) anesthesia and
bile was collected during a 30 minute period. Bile production was assessed by
weight. Subsequently, a large blood sample was collected by cardiac puncture.
Three mice of each group were used for investigating liver pathology and for
RNA isolation. Mice were killed by cardiac puncture and the liver was perfused with
ice-cold saline, excised, weighed and used for examining liver morphology after
paraformaldehyde fixation and HE staining, or, after snap freezing in liquid
isopentane, for membrane isolation and RNA isolation.
Western blot analysis and RT-PCR analysis: Part of the collected livers was used
to isolate total and plasma membrane fractions as previously described [17], for
assessment of Ntcp, Oatp-1, bile salt export pump (bsep) and SR-BI protein levels.
Protein levels of Na+/K+-ATPase was used as a reference signal. Protein (75 mg)
was separated using SDS gel electrophoresis (13% Ready gels, BioRad
Laboratories, Hercules, CA, USA) and subsequently blotted onto nitrocellulose
(Hybond-ECL, Amersham, UK) and probed with anti-Ntcp-immunoglobulin IgG K4,
anti-oatp1-immunoglobulin IgG K10 (both kindly provided by B. Stieger, Zürich,
Switzerland [18]), anti-spgp (bsep) (rat) IgG K12 (kindly provided by Dr. M Müller,
Groningen anti SR-BI IgG (Kindly provided by Dr. M. Krieger, Boston, USA) or goat
anti-rabbit-Na+/K+-ATPase antibody against its a-subunit (kindly provided by Dr.
WHM Peters, Nijmegen, The Netherlands). Immune complexes were detected
using horseradish peroxidase-conjugated donkey anti-rabbit-IgG by ECL Western
blotting Kit (Amersham, UK).
Total RNA of liver and intestine was isolated using a combination of the
Trizol method (GIBCO BRL, Grand Island, NY) with the Promega SV-RNA kit
(Promega, Madison WI, USA) to obtain qualitative amounts of RNA for further
analysis. Steady state mRNA levels of Ntcp, sPgp, mrp2 in liver were determined
by semi-quantitative RT-PCR, b-actin mRNA levels were used as a housekeeping
signal. The following primers sets were used; Ntcp, sense primer:
CTGCCGCCTGGCTTTGGCCA, anti sense primer: CTGGAGCAGGTGGTCATCTG;
sPgp, sense primer: TCTGGACAAAGCCAGAGAGG, anti sense primer:
AGAGCTATGACAACCCGCAG; mrp2, sense primer: AATCATCCCTCACCAACTGC,
anti sense primer: CTTCATGGAGCAACCCAAGT and b-actin, sense primer:
AACACCCCAGCCATGTAGG, anti sense primer: ATGTCACGCACGATTTCCC. The
relative intensity of the different bands were determined using a CCD video
camera of the ImageMaster VDS system (Pharmacia, Upsulla, Sweden).
Fecal bile salt analysis: Male and female Mdr2(-/-) and Mdr2(+/+) mice were housed
individually and total fecal production during a one week-period was separated
from the wood shavings. Fecal samples were lyophilized and weighed. Aliquots
hereof were used for determination of acidic sterol content by gas liquid
chromatographic procedures described [19,20].
Analyses: Plasma total cholesterol, free cholesterol and triglycerides (glycerol
blanking) were measured using commercially available kits, according to the
manufacturer’s instructions (Boehringer Mannheim, Mannheim, Germany).
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Plasma free fatty acids and phospholipids were determined using commercial kits
from WAKO (WAKO Chemicals GmbH, Neuss, Germany). Contents of cholesterol
in bile and cholesterol (ester) and triglycerides in liver tissue was determined after
lipid extraction [21] as described previously [22]. Protein content of the liver
homogenates was determined according to Lowry et al. [23], with BSA as
standard. Total bile salt concentration in bile and plasma were determined by an
enzymatic fluorimetric assay [24]. Plasma and biliary bilirubin (total and
conjugated), alanine-aminotransferase (ALT), aspartate-aminotransferase (AST)
and alkaline phosphatase (AP), were determined by standard procedures at the
Central Clinical Laboratory at the University Hospital Groningen.
Statistical analysis: All results are presented as means – standard deviations for
the number of animals indicated. Differences between dietary groups was
determined by one-way ANOVA analysis [25], with posthoc comparison by
Newmann Keuls t-test [25], for both Mdr2(-/-) and Mdr2(+/+) mice. Differences
between Mdr2(-/-) and Mdr2(+/+) mice were determined by Mann Whitney U-test
analysis [25] for the different dietary groups. Level of significance for all statistical
analysis was set at p < 0.05. Analysis was performed using SPSS for Windows
software (SPSS, Chicago, IL, USA)
RESULTS
Plasma lipid levels:  The first question was  whether reduced plasma cholesterol
levels in Mdr2(-/-) mice could be (partially) restored by feeding phosphatidylcholine
(PC) and/or cholesterol. Feeding PC and/or cholesterol did not have any relevant
effect on plasma total cholesterol or cholesteryl ester levels in Mdr2(+/+) or Mdr2(-/-)
mice, with the exception of a small increase in PC + cholesterol-fed male mice
(Figure 2). Cholesterol levels remained significantly lower in Mdr2(-/-) mice
compared with controls under all dietary conditions, in males as well as in
females, during the experiments. There were no marked effects on plasma
triglycerides or phospholipids in male or female Mdr2(+/+) and Mdr2(-/-) mice on
either diet (data not shown).
Hepatic cholesterol content: The absence of any effect of cholesterol feeding on
plasma cholesterol concentrations in Mdr2(-/-) mice could theoretically be due to
Figure 2: Plasma cholesterol levels determined
at day 21 in male (A) and female (B) Mdr2(+/+)
and Mdr2(-/-) mice on reference (ref) and
phospholipid-containing (PC) diets with or
without additional cholesterol (C). Samples were
taken by tail bleeding as described in the
method section. Data represent mean plasma
cholesterol concentrations (in mM) – SD, n = 8
per group. Differences for the diet groups were
analyzed by one-way ANOVA analysis with
Newmann-Keuls t-test posthoc analysis, (#) p <
0.05. Differences between Mdr2(-/-) and control
mice were analyzed using Mann Whitney exact
U-test. Concentrations in Mdr2(-/-) mice were
significantly lower in Mdr2(+/+) mice in all groups
(*). White bars: Mdr2(+/+) mice; black bars: Mdr2(-
/-)
 mice.
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impaired uptake of dietary cholesterol from the intestine [16]. We therefore
measured hepatic cholesterol content as a reflection of intestinal uptake. Figure 3
shows the hepatic total cholesterol content, expressed in mmol/liver, in male and
female Mdr2(+/+) and Mdr2(-/-) mice on the reference and reference + cholesterol
diets. Mdr2(+/+) and Mdr2(-/-) mice showed a similar increase in total hepatic
cholesterol content after one week of cholesterol supplementation. Similar results
were found with additional PC (data not shown). This increase was due to an
increase in hepatic cholesterol ester content: hepatic free cholesterol remained
unchanged in all groups. Hepatic triglyceride levels increased 1.5-2 times on
cholesterol-containing diets in Mdr2(+/+) mice (data not shown): no changes were
observed in the Mdr2(-/-) mice.
Hepatic SR-BI expression: Protein levels of SR-BI, identified as the HDL-receptor
[26,27], appeared to be slightly higher in plasma liver membrane fractions of Mdr2(-
/-)
 mice than of Mdr2(+/+) mice fed the reference diet (Figure 4). In both strains,
however, dietary cholesterol was associated with a marked reduction in hepatic
SR-BI levels.
The second question was whether the strongly reduced capacity to remove
cholesterol via bile in Mdr2(-/-) mice would affect hepatic handling of the relatively
mild dietary cholesterol load.  During blood sampling, it was obvious that plasma
of Mdr2(-/-) mice became jaundiced within three days of cholesterol feeding.
Because phospholipid feeding had no additional effect on plasma lipid or bilirubin
levels subsequent studies were focused on the effects of cholesterol
supplementation to the reference diet.
Figure 3: Hepatic cholesterol content in
livers of Mdr2(+/+) and Mdr2(-/-) male and
female mice on reference (ref) or
reference + 0.25% cholesterol (ref + C)
diets. Values represent total cholesterol
in mmol per liver, n = 5 per group.
Differences between the dietary groups
were determined by one-way ANOVA
analysis and Newmann-Keuls t-test
posthoc analysis, (#) p < 0.05. White
bars: Mdr2(+/+) mice; Black bars: Mdr2(-/-)
mice.
Figure 4: Western blot analysis of
hepatic plasma membrane fractions for
Scavenger receptor class B, type 1 (SR-
BI) and Na+, K+-ATPase in female
Mdr2(+/+) and Mdr2(-/-) mice on reference
(R) or reference + cholesterol (C) diets.
The amounts of protein loaded onto the
gel were standardized to activities of
Na/K-ATPase, as described [17]. Data
shown are representative for 2 separate
membrane preparations (each of 2
pooled mouse livers) per group. Similar
data were obtained for male mice.
Supplementation of PC to the diet had
no additional effects on SR-BI protein
levels.
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Plasma bile salt, bilirubin, transaminases and alkaline phosphatase levels:
Plasma bile salts, bilirubin, transaminases and alkaline phosphatase were
determined at three and seven days after initiation of cholesterol feeding in male
and female Mdr2(-/-) and control mice. Bile salt levels in Mdr2(-/-) mice before
initiation of cholesterol feeding were significantly higher than those of sex-matched
controls, as previously reported [8], whereas bilirubin levels did not differ. As
shown in Figure 5, plasma bilirubin (panel A) and bile salts (panel B) levels
increased during cholesterol feeding in Mdr2(-/-) mice, in particular in the females.
As shown in Table 2, both the conjugated and the unconjugated  fraction of plasma
bilirubin was significantly increased in Mdr2(-/-) mice upon cholesterol feeding.
Table 2: Conjugated and unconjugated bilirubin in plasma of male and female Mdr2(+/+) and
Mdr2(-/-) mice fed reference (Ref) or reference + cholesterol (Ref + C) diets. Blood samples
were taken at the end of the experiment by cardiac puncture as described in the material
and method section. (*) significant difference Mdr2(-/-) versus Mdr2(+/+), Mann-Whitney U test,
p < 0.05, n = 8 per group. (#) significant difference of one dietary group versus other dietary
groups, one-way ANOVA, Newmann-Keuls t-test p < 0.05, n = 8 per group.




Male +/+ Ref bd 2.7 – 1.2
Ref + C 0.7 – 1.2 4.0 – 2.0
Female +/+ Ref bd 4.0 – 2.0
Ref + C 0.7 – 1.2 3.3 – 1.2
Male -/- Ref 2.0 – 0.1 * 4.0 – 2.0
Ref + C 6.0 – 0.1 *# 6.7 – 1.2 #
Female -/- Ref 0.7 – 1.2 3.3 – 1.2
Ref + C 22.7 18.9 *# 32.7 – 22.7 *#
bd = below detection limit
Plasma transaminase (AST and ALT) and  alkaline phosphatase (AP) activities in
male and female Mdr2(-/-) mice kept on reference diet were significantly higher than
in control mice, as shown before [8,28]. Feeding cholesterol had no further effect
on AST and ALT in Mdr2(+/+) and Mdr2(-/-) mice of either sex, whereas cholesterol
feeding induced an increase in AP activity in male and female Mdr2(-/-) mice (Table
3).
Figure 5: Plasma bilirubin (panel A) and
bile salt (panel B) levels in mice on
reference diet before and during
cholesterol feeding, i.e., at days 14, 17
and 21. Values represent mean – SD in
mmol/L, n = 8 per group. Differences
between dietary groups were determined
by means of a one-way ANOVA with
Newmann-Keuls t-test posthoc analysis, (#)
p < 0.05. Differences between Mdr2(-/-) and
Mdr2(+/+) mice were analyzed for each
dietary group and males and females
separately by Mann-Whitney exact U-test,
(*) p < 0.05. Filled symbols: Mdr2(+/+) mice;
open figures: Mdr2(+/+) mice; squares: male
mice; circles: female mice.
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Table 3: Alanine-aminotransferase (ALT), aspartate-aminotransferase (AST) and alkaline
phosphatase (AP) activities in plasma of male and female Mdr2(+/+) and   Mdr2(-/-) mice fed
reference (Ref) or reference + cholesterol (Ref + C) diets. Blood samples were taken at the
end of the experiment by cardiac puncture as described in the material and method section.
(*) significant difference Mdr2(-/-) versus Mdr2(+/+), Mann-Whitney U test, p < 0.05, n = 8 per
group. (#) significant difference of one dietary group versus other dietary groups, one-way
ANOVA, Newmann-Keuls t-test p < 0.05, n = 8 per group.
Mouse group Diet AST (U/L) ALT (U/L) AP (U/L)
Male +/+ Ref 56 – 13.1 20.7 – 6.4 bd
Ref + C 53.3 – 9.5 28.0 – 7.2 bd
Female +/+ Ref 78.1 – 12.2 25.3 – 1.2 bd
Ref + C 96.0 – 28.4 21.3 – 1.2 bd
Male -/- Ref 364.7 – 292.4 * 290.0 – 303.7 * bd
Ref + C 456.6 – 128.2 * 375.0 – 76.8 * 4.0 – 0.01 * #
Female -/- Ref 397.3 – 43.2 * 206.7 – 14.5 * 2.0 – 0.01 *
Ref + C 362.0 – 150.6 * 334.7 – 120.4 * 10.0 – 8.7 * #
bd = below detection limit
Bile flow and bile composition: The increases in plasma bilirubin and bile salt
levels in the Mdr2(-/-) mice on the cholesterol-containing diet could be indicative for
induction of cholestasis. Therefore, we analyzed bile flow and biliary output of bile
salts, bilirubin and cholesterol in the different groups, as summarized in Figure 6.
As previously shown [8], bile flow in Mdr2(-/-) mice is clearly increased when
compared with Mdr2(+/+) mice, both in males and females. Although expected on
basis of the elevated plasma bile salts, there was no decrease in bile flow or
biliary bile salt secretion in cholesterol-fed Mdr2(-/-) mice compared to control-fed
Mdr2(-/-) mice. Similarly, no changes where observed in biliary bilirubin output
across the groups. Feeding cholesterol led to an increased biliary cholesterol
output in Mdr2(+/+) mice. Cholesterol output in Mdr2(-/-) mice was strongly impaired
Figure 6: Bile flow, biliary salt output
and biliary cholesterol output in male
and female mice on reference (ref) and
reference + cholesterol (ref + C) diets.
Bile flow is given in mL per minute per
100g body weight, bile salt output and
cholesterol output in nmol per minute
per 100g body weight, n = 5 per group.
Differences between the dietary groups
were analyzed by one-way ANOVA
analysis and Newmann-Keuls t-test
posthoc analysis, (#) p < 0.05.
Differences between Mdr2(-/-) and
Mdr2(+/+) mice were analyzed for each
dietary group and males and females
separate by Mann-Whitney exact U-test,
(*) p < 0.05. White bars: Mdr2(+/+) mice;
black bars: Mdr2(-/-) mice.
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compared with the Mdr2(+/+) mice [8,10] and did not change when cholesterol was
added to the diet. Biliary phospholipid output was not changed in Mdr2(+/+) mice of
either sex in any of the dietary groups and remained below detection level in Mdr2(-
/-)
 mice (data not shown). Analysis of fecal acidic sterol content, performed in male
animals only, revealed that feeding of cholesterol led to an approximately two-fold
increased fecal bile salt output in Mdr2(+/+) mice, i.e., from 6.5 – 1 mmol/day on the
reference to 12.2 – 2 mmol/day on the reference + cholesterol diet, respectively. In
contrast, no increase in fecal bile salt output was noted in cholesterol-fed male
Mdr2(-/-) mice (7.4 – 2 versus 5.9 – 1 mmol/day).
Protein and steady state mRNA levels of hepatic transporters: We have
previously reported reduced hepatic levels of Na+-taurocholate cotransporting
protein (Ntcp) and impaired taurocholate transport in liver plasma membrane
fractions in Mdr2(-/-) mice on a regular chow diet [28]. Therefore, we checked effects
of cholesterol feeding on Ntcp protein levels in plasma membrane fractions
isolated from livers of male and female Mdr2(+/+) and Mdr2(-/-) mice on the four
experimental diets by Western blotting (Figure 7) and on hepatic mRNA levels by
semi-quantitative RT-PCR (Figure 8).
The Mdr2(-/-) mice showed clearly decreased Ntcp protein levels compared with
sex-matched Mdr2(+/+) mice on reference diet, in accordance with previous studies
[28]. Addition of cholesterol to the reference diet caused a further decrease in Ntcp
levels in Mdr2(-/-) mice and also to decreased Ntcp levels in Mdr2(+/+) mice. Steady
state mRNA levels of Ntcp were lower in female Mdr2(-/-) mice than in sex-matched
controls and further declined upon cholesterol feeding. No significant changes in
Ntcp mRNA levels were found in male mice on either diet. Surprisingly, oatp-1
protein levels were higher in Mdr2(-/-) mice than in controls, and only reduced by
dietary cholesterol in the latter. Likewise, bsep protein levels appeared to be
increased in Mdr2(-/-) mice when compared to controls but no marked effects of
cholesterol feeding were noted in either strain. No clear effect of Mdr2-Pgp-
deficiency or cholesterol feeding on mRNA levels of these transporters as well as
of mrp2 (canalicular organic anion transporter) were observed, with the exception
of a modest but significant induction of bsep mRNA levels by cholesterol feeding in
female mice.
Figure 7: Western blot analysis of
hepatic plasma membrane fractions
for Na+-taurocholate cotransporting
protein (Ntcp), Organic anion
transporter protein-1 (oatp-1), bile salt
export pump (bsep) and Na+, K+-
ATPase in male and female control
and Mdr2(-/-) mice on reference (R) or
reference + cholesterol (C) diets. The
amounts of protein loaded onto the
gel were standardized to activities of
Na/K-ATPase and alkaline
phosphatase as described [17]. Data
shown are representative for 2
separate membrane preparations
(each of 2 pooled mouse livers) per
group
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DISCUSSION
Impaired biliary lipid secretion in Mdr2(-/-) mouse is associated with a marked
decrease in plasma HDL cholesterol in presence of normal hepatic cholesterol
levels. To investigate whether the decrease in plasma cholesterol levels in the
Mdr2(-/-) mouse is directly due to the impaired delivery of phospholipids and/or
cholesterol to the intestine, we fed Mdr2(-/-) mice diets supplemented with these
lipids for a considerable period of time. The biliary pathway delivers approximately
six to eight times more phospholipids and two to three times more cholesterol to
the intestine of Mdr2(+/+) mice than dietary intake does when animals are fed
regular lab chow. We have added phosphatidylcholine and/or cholesterol to the
diet in amounts exceeding normal biliary delivery by a factor of approximately ten
and thirty, respectively, to ensure the presence of sufficient amounts of these lipids
in the intestinal lumen.
No changes were observed in plasma cholesterol levels after feeding
Mdr2(+/+) and Mdr2(-/-) mice diets supplemented with PC. This observation is not in
line with data from Rioux et al. [29], who found a decrease in plasma cholesterol
and triglyceride levels after feeding a phospholipid-enriched diet for a period of
only four days to rats. These deviating results are possibly due to differences in
duration of phospholipid feeding, phospholipid source and/or animal species.
Plasma cholesterol transiently increased in Mdr2(+/+) mice during PC + cholesterol
feeding (not shown), which is in agreement with findings of others [30]. The
addition of PC and/or cholesterol did not normalize the plasma cholesterol levels
in Mdr2(-/-) towards levels found in control mice. We analyzed hepatic cholesterol
levels to assess whether dietary cholesterol was actually absorbed in Mdr2(-/-)
mice. Since a similar increase in hepatic cholesterol content after cholesterol
feeding was found in Mdr2(+/+) and Mdr2(-/-) mice, dietary cholesterol must have
been absorbed to a considerable degree in Mdr2(-/-) mice. Yet, this influx of dietary
cholesterol was not reflected in elevation of plasma cholesterol levels, even in
spite of the fact that Mdr2(-/-) mice are unable to increase biliary cholesterol
disposal as Mdr2(+/+) mice do (Figure 6). These results indicate that the secretion
Figure 8: Steady state mRNA level of Ntcp,
oatp-1, bsep, mrp2 and ß-actin was
determined by RT-PCR in control and Mdr2(-/-
)
 mice (A). Data shown are representative for
at least 3 separate RNA isolations per
group. The mRNA levels were quantitated
by densitometric analysis, related to ß-actin
levels, and presented as % of control value
(Mdr2(+/+) mice on reference diet) (B). The
values represent mean – SD ( n=3-4 per
group). Differences between the dietary
groups were analyzed by one-way ANOVA
analysis and Newmann-Keuls t-test posthoc
analysis, (*) p < 0.05.
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of phospholipids and/or cholesterol into bile, and not the mere presence of these
lipids in the intestine, is important in the regulation of plasma HDL cholesterol
levels. We reported earlier that mRNA levels of apolipoprotein A-I, the major
apolipoprotein on HDL, did not differ between Mdr2(-/-) and control mice. Other
proteins involved in the regulation of HDL levels in plasma, i.e., the HDL-receptor
(SR-BI) [26,27] and the recently described Tangier disease gene, ABC-1 [31-33],
could play a role in the decreased HDL levels found in Mdr2(-/-) mice. Indeed, a
slightly increased protein expression of SR-BI in Mdr2(-/-) mice might contribute to
low HDL levels found in these animals, as has been found after adenoviral-
mediated overexpression of SR-BI in mice [34]. However, cholesterol feeding
decreased hepatic SR-BI protein levels in both Mdr2(-/-) and control mice, in line
with the observation that hepatic SR-BI protein levels are reduced in cholesterol-
fed rats [35]. Decreased SR-BI expression was not associated with increased HDL
levels in either group, suggesting that, under the conditions employed, hepatic SR-
BI is not a major determinant of plasma cholesterol levels in mice.
Cholesterol feeding led to a strong increase of plasma bilirubin and bile salt
levels in Mdr2(-/-) mice. Conjugated as well as unconjugated bilirubin levels were
increased: the latter may be a result of erythrocyte damage induced by the high bile
salt levels in Mdr2(-/-) mice leading to increased conversion of hemoglobin into
bilirubin. The increase in conjugated bilirubin is indicative for altered hepatic
handling. Plasma transaminase activities were significantly higher in Mdr2(-/-)
compared to controls on the reference diet and did not increase further after
cholesterol feeding. Cholesterol feeding in Mdr2(-/-) mice did lead to a mild
increase in plasma alkaline phosphatase activity, indicative for alterations at the
level of the canalicular membrane. This, together with the increased in plasma
bilirubin and bile salt levels at first sight suggested the induction of cholestasis by
dietary cholesterol. However, no changes in bile flow and/or biliary bile salt and
bilirubin output were induced by dietary cholesterol in Mdr2(-/-) mice. Biliary
cholesterol secretion was significantly increased in control mice showing the
ability to remove excess dietary cholesterol via this pathway in the presence of
normal mdr2 Pgp function. Furthermore, cholesterol feeding induced bile salt
synthesis in Mdr2(+/+) mice, as reflected in increased fecal bile salt output. The
Mdr2(+/+) mice apparently are capable to eliminate, at least in part, excess dietary
cholesterol via these routes, whereas the Mdr2(-/-) mice are not. It has been
described that feeding of excess cholesterol leads to increased bile salt loss from
the intestine in rats [36] and humans [37], which has been attributed to
cholestyramine-like effects of dietary cholesterol and/or a direct stimulatory effect
on hepatic bile salt synthesis. It should be noted that in the studies mentioned
diets contained 1% or 2% cholesterol, while we used only 0.25% cholesterol. It
should also be noted that no changes were found in mRNA levels of cholesterol
7a-hydroxylase or cholesterol 27-hydroxylase, the two key enzymes in bile salt
synthesis (data not shown) in Mdr2(+/+) or Mdr2(-/-) mice. Increased activities and
mRNA levels of these enzymes have been described during feeding of 1% or 2%
cholesterol in rats [36] but also in these studies no changes in activity or mRNA
levels were observed when feeding less than 1% cholesterol.
A simple calculation, based on previously reported values [8], reveals that at
least 3% and 15% of the bile salt pool resides in the plasma compartment in
cholesterol-fed Mdr2(-/-) male and female mice, respectively. It may be that a slightly
induced bile salt synthesis rate/pool size induced by cholesterol feeding exceeds
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the maximal transport capacity for bile salt secretion in Mdr2(-/-) mice [8], leading to
regurgitation in the plasma compartment. Increased plasma bile salt levels,
already present during feeding of regular chow [8] and reference diet (this study),
may further down-regulate Ntcp levels at the sinusoidal membrane [28], thereby
exacerbating the hypercholanemic response. Alternatively, down-regulation of Ntcp
may also reflect a physiological response to the cholesterol feeding per se, since
such a down-regulation was also observed in Mdr2(+/+) mice fed cholesterol that
did not show elevated plasma bile salt levels. It may be that down-regulation of
Ntcp during cholesterol feeding functions to prevent feedback inhibition of bile salt
synthesis by circulating bile salts, thereby facilitating conversion of excess
cholesterol to bile salts. In fact, it has recently been shown that the promoter of
Ntcp in rats contains a putative sterol regulatory element [38], which could explain
these findings and supports our hypothesis. Hepatic oatp-1 protein levels
appeared to be increased in the Mdr2(-/-) mice compared to control mice in this
study. Since murine oatp-1 is able to transport taurocholate [39], this may be a
compensatory response of the Mdr2(-/-) liver ensure maintenance of hepatic bile
salt flux. The decreased protein levels of oatp-1 in control mice after cholesterol
feeding may act synergistically with reduced Ntcp protein levels to re-depress bile
salt biosynthesis and reflects a physiological adaptation to remove excess
cholesterol from the liver. Hepatic protein levels of the bile salt export pump were
found to be increased in male and female Mdr2(-/-) mice, which, to the best of our
knowledge, is the first description of increased protein expression of this important
transporter under (patho)physiological conditions. Since virtually nothing is known
about regulation of bsep, we can only speculate on the underlying mechanisms.
Since no difference in bsep mRNA were found between Mdr2(+/+) and Mdr2(-/-) mice,
our data suggest a post-transcriptional event to be responsible for this effect of
mdr2 Pgp-deficiency, that may be aimed at maintenance of biliary bile salt
secretion capacity in the absence of biliary lipids [29].
The observation that effects of dietary cholesterol on plasma bile salt levels
were more pronounced in female than in male Mdr2(-/-) mice is in agreement with
the fact that  “basal” bile salt levels are already increased to a larger extent in
female Mdr2(-/-) mice. The reason for this divergence between males and females
is not yet clear, but may be related to the higher degree of liver pathology seen in
females [11,12]. The effects of dietary cholesterol in Mdr2(-/-) mice were not due to
changes in bile salt composition, since no changes were found by gas
chromatographic analysis of biliary bile salt composition in either Mdr2(-/-) or
Mdr2(+/+) mice fed cholesterol (data not shown). Bilirubin output in to bile was not
affected in Mdr2(-/-) mice fed cholesterol, which may indicate that biliary secretion in
these animals already, under normal conditions, operates at maximal capacity. We
speculate that the capacity of canalicular secretion of (conjugated) bilirubin in
Mdr2(-/-) mice is compromised due to reduced protein levels of mrp2 (JML de Vree,
unpublished results), the major canalicular bilirubin transporter [40], although
steady state mRNA levels of mrp2 were not affected by mdr2 Pgp-deficiency or
cholesterol feeding.
In conclusion, feeding of phospholipids and/or cholesterol at levels
exceeding the physiological biliary input of these lipids about ten- to thirty-fold does
not normalize low plasma cholesterol levels in Mdr2 Pgp-deficient mice. The
results of this study imply that biliary secretion, and not the presence of these
lipids in the intestine, exerts specific functions in the regulation of plasma
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cholesterol levels. Furthermore, cholesterol feeding of Mdr2 Pgp-deficient mice
gives rise to “cholestatic” plasma levels of bilirubin and bile salts without evident
changes in bile formation, indicating that Mdr2(-/-) mice are not able to handle the
excess dietary cholesterol. These “cholestatic” features possibly reflect the
consequences of relative small alterations in the capacity of hepatic uptake and/or
canalicular secretion systems in the Mdr2(-/-) mice. Down-regulation of Ntcp during
cholesterol feeding may be a specific physiological response to accelerate
removal of excess cholesterol from the body by preventing feedback repression of
hepatic bile salt synthesis.
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